Mason Freeman - Jan 11, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
EVP Clinical Development
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 11, 2022
Transactions value $
$41,600
Form type
4
Date filed
1/13/2022, 03:28 PM
Previous filing
Jan 6, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CINC Common Stock Purchase $40K +2.5K $16.00 2.5K Jan 11, 2022 Direct
transaction CINC Common Stock Purchase $1.6K +100 $16.00 100 Jan 11, 2022 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.